Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
出版年份 2020 全文链接
标题
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-21
DOI
10.1007/s00228-020-02963-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids
- (2020) Michael C Peters et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
- (2020) M. Montopoli et al. ANNALS OF ONCOLOGY
- Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
- (2020) Markus Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
- (2020) Guang Yang et al. HYPERTENSION
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma—implications for COVID-19
- (2020) Peter Bradding et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients
- (2020) Zsuzsanna Suba JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- (2020) Andy Goren et al. Journal of Cosmetic Dermatology
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- COVID-19: Melatonin as a potential adjuvant treatment
- (2020) Rui Zhang et al. LIFE SCIENCES
- Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
- (2018) Marhiah C. Montoya et al. mBio
- Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men
- (2017) A Bukowska et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
- (2016) Mizuki Yamamoto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems
- (2016) Jiaxi Xu et al. Frontiers in Physiology
- Protease inhibitors targeting coronavirus and filovirus entry
- (2015) Yanchen Zhou et al. ANTIVIRAL RESEARCH
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Julie Dyall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17
- (2014) Jing Ren et al. Cellular & Molecular Immunology
- Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole In Vivo
- (2014) A. Butts et al. mBio
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
- (2013) Manuel Haschke et al. CLINICAL PHARMACOKINETICS
- Androgen Regulation of the TMPRSS2 Gene and the Effect of a SNP in an Androgen Response Element
- (2013) Liesbeth Clinckemalie et al. MOLECULAR ENDOCRINOLOGY
- Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer
- (2010) J. N. Kyula et al. CLINICAL CANCER RESEARCH
- ADAM-17: the enzyme that does it all
- (2010) Monika Gooz CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Molecule-specific Effects of Angiotensin II-Receptor Blockers Independent of the Renin-Angiotensin System
- (2008) T. W. Kurtz et al. AMERICAN JOURNAL OF HYPERTENSION
- Tissue-specific regulation of ACE/ACE2 and AT1/AT2receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-α knock-out mice
- (2008) K. Bridget Brosnihan et al. EXPERIMENTAL PHYSIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started